Phibro Animal Health Co. (NASDAQ:PAHC) is expected to post earnings of $0.33 per share
Analysts expect Phibro Animal Health Co. (NASDAQ:PAHC) to report earnings of $0.33 per share for the current fiscal quarter, reports Zacks Investment Research. Zero analysts provided earnings estimates for Phibro Animal Health, with the highest EPS estimate at $0.34 and the lowest estimate at $0.32. Phibro Animal Health reported earnings of $0.34 per share in the same quarter last year, which would indicate a negative 2.9% year-over-year growth rate. The company is expected to announce its next earnings report after the market closes on Wednesday, February 9.
According to Zacks, analysts expect Phibro Animal Health to report annual earnings of $1.28 per share for the current year, with EPS estimates ranging from $1.27 to $1.29. For the next fiscal year, analysts expect the company to post earnings of $1.34 per share, with EPS estimates ranging from $1.30 to $1.38. Zacks Investment Research’s earnings per share averages are an average average based on a survey of sell-side research analysts who provide coverage for Phibro Animal Health.
Phibro Animal Health (NASDAQ:PAHC) last reported quarterly earnings data on Tuesday, November 2. The company reported EPS of $0.25 for the quarter, missing Zacks consensus estimate of $0.29 per ($0.04). Phibro Animal Health achieved a net margin of 5.70% and a return on equity of 22.34%. The company had revenue of $214.70 million in the quarter. During the same period of the previous year, the company posted EPS of $0.27.
A number of analysts have recently released reports on the company. Barclays downgraded Phibro Animal Health from an “underweight” rating to an “equal weight” rating and set a target price of $23.00 on the stock in a Monday, January 10 research report. Morgan Stanley assumed coverage of Phibro Animal Health shares in a Thursday, Nov. 18, research report. They issued an “equal weight” rating and a target price of $23.00 for the company.
Shares of PAHC opened at $18.50 on Friday. Phibro Animal Health has a fifty-two week minimum of $18.26 and a fifty-two week maximum of $31.00. The company’s fifty-day moving average is $20.41 and its two-hundred-day moving average is $22.11. The company has a market capitalization of $749.32 million, a PE ratio of 15.42 and a beta of 0.57. The company has a quick ratio of 1.82, a current ratio of 3.27 and a debt ratio of 1.69.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 15. Investors of record on Wednesday, November 24 received a dividend of $0.12 per share. The ex-dividend date was Tuesday, November 23. This represents an annualized dividend of $0.48 and a dividend yield of 2.59%. The dividend payout ratio of Phibro Animal Health is currently 40.00%.
A number of hedge funds have recently changed their PAHC holdings. FMR LLC increased its position in shares of Phibro Animal Health by 131,032.6% during the 2nd quarter. FMR LLC now owns 281,935 shares of the company worth $8,142,000 after purchasing an additional 281,720 shares during the period. Louisiana State Employees Retirement System raised its position in Phibro Animal Health 6.5% in Q3. Louisiana State Employees Retirement System now owns 9,800 shares of the company valued at $211,000 after purchasing an additional 600 shares last quarter. Amalgamated Bank acquired a new stake in Phibro Animal Health in Q2, valued at approximately $319,000. First Hawaiian Bank raised its position in Phibro Animal Health by 5.8% in the third quarter. First Hawaiian Bank now owns 11,895 shares of the company valued at $256,000 after buying 657 additional shares in the last quarter. Finally, Invesco Ltd. raised its position in Phobro Animal Health by 185.0% in the 2nd quarter. Invesco Ltd. now owns 475,067 shares of the company valued at $13,721,000 after purchasing an additional 308,372 shares in the last quarter. 50.41% of the shares are held by hedge funds and other institutional investors.
About Phibro Animal Health
Phibro Animal Health Corp. is engaged in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition and Performance Products. The Animal Health segment develops and markets antibacterial products, nutritional specialties and vaccines.
Recommended Story: Economic Bubble
Get a Free Copy of Zacks’ Research Report on Phibro Animal Health (PAHC)
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Phibro Animal Health right now?
Before you consider Phibro Animal Health, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and Phibro Animal Health didn’t make the list.
Although Phibro Animal Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here